Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyReN Study: Cyporin-N (cyclosporine) vs rebamipide ophthalmic drops in dry eye syndrome
KCT0011522Phase 4Recruiting
- Sponsor
- Kyungpook National University Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rebamipide in dry eye syndrome (DED), sponsored by Kyungpook National University Hospital. Started Nov 2025; status: recruiting.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0011522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011522.